Am J Transplant, Volume 19, Suppl 3 Archives - Page 80 of 214 - ATC Abstracts

2019 American Transplant Congress
Anti-Fungal Prophylaxis in Lung Transplant: A Systematic Review/Meta-Analysis
K. Pennington, M. Baqir, P. Erwin, H. Murad, R. Razonable, C. C. Kennedy
Mayo Clinic, Rochester, MN
*Purpose: Invasive fungal infections (IFI) increase morbidity and mortality after lung transplant. Despite this, anti-fungal prophylaxis (AFP) in lung transplant recipients (LTR) varies by prophylactic…
2019 American Transplant Congress
Panniculectomy at the Time of Living Donor Renal Transplantation: An Eight Year Experience
L. M. Ngaage¹, A. Elegbede², K. K. Tasidina¹, S. Gebran³, E. Rada¹, A. J. Nam³, J. R. Scalea⁴, S. Niederhaus⁴, D. Singh¹, J. S. Bromberg⁴, S. T. Bartlett⁴, Y. M. Rasko¹
¹Department of Plastic Surgery, University of Maryland Medical Center, Baltimore, MD, ²Department of Plastic & Reconstructive Surgery, Johns Hopkins Hospital / University of Maryland Medical Center, Baltimore, MD, ³Division of Plastic & Reconstructive Surgery, R Adams Cowley Shock Trauma Center, Baltimore, MD, ⁴Department of Transplant Surgery, University of Maryland Medical Center, Baltimore, MD
*Purpose: Removal of the pannus, or panniculectomy, can be performed as a prophylactic procedure preceding renal transplantation to enable obese patients to meet criteria for…
2019 American Transplant Congress
The Medical Intensive Liver Unit: A Novel Multi-disciplinary Program For The Intensive Care Of Patients With Advanced Liver Disease
C. C. Lindenmeyer¹, G. Flocco¹, A. Sobotka¹, L. Kokoczka², B. Dolan², C. Strauser², C. Romero-Marrero¹, E. Mireles-Cabodevila², H. Khouli², C. Quintini³, A. Kapoor²
¹Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, OH, ²Department of Critical Care Medicine, Cleveland Clinic, Cleveland, OH, ³Transplantation Center, Cleveland Clinic, Cleveland, OH
*Purpose: Patients with advanced liver disease, particularly those with acute decompensation or acute liver failure (ALF) requiring intensive care unit (ICU) admission, are at elevated…
2019 American Transplant Congress
Beyond Medication Education: Opportunities for Improvement in Health Education of Solid Organ Transplant Recipients
Y. J. Bababekov, Y. Hsu, C. G. Rickert, Y. Hung, J. A. Fishman, J. F. Markmann, L. Dageforde, D. C. Chang, H. Yeh
Department of Surgery, Massachusetts General Hospital, Boston, MA
*Purpose: As immunosuppressive medications are crucial to graft and patient survival, transplant centers dedicate significant resources to medication education. However, patient outcomes also depend on…
2019 American Transplant Congress
International Multicenter Study Evaluating Clinical Outcomes Associated with Acute Antibody-Mediated Rejection
S. Corman¹, I. Hirji², E. Brouwer², S. H. Park¹, C. Macahilig³, A. Vergani², T. Bo², P. Wolthoff³, P. Keown⁴
¹Pharmerit International, Bethesda, MD, ²Shire, Cambridge, MA, ³Medical Data Analytics, Parsippany, NJ, ⁴University of British Columbia, Vancouver, BC, Canada
*Purpose: Evaluating factors that impact clinical outcomes of patients with acute antibody-mediated rejection (aAMR) may help manage and improve outcomes following kidney transplant. The objective…
2019 American Transplant Congress
Immediate Post Reperfusion In Vivo Transcriptional Responses of Individual Human Renal Allograft Cell Populations to Circulating Anti-Angiotensin II Type I Receptor Antibody
C. M. Castro -Rojas¹, N. Salomonis², K. Chetal², R. R. Alloway³, E. Woodle³, D. A. Hildeman¹
¹Immunobiology, Cincinnati Children's Hospital, Cincinnati, OH, ²Biomedical Informatics, Cincinnati Children's Hospital, Cincinnati, OH, ³Transplantation, University of Cincinnati College of Medicine, Cincinnati, OH
*Purpose: Pre-existing anti-angiotensin II type I receptor (AT1R) antibodies can be a significant driver of allograft rejection. Indeed, prior work has shown that AT1R antibodies…
2019 American Transplant Congress
Resource Utilization in Hepatocellular Carcinoma Liver Transplantation before and after the Six Month Wait Time
J. Sokolich¹, W. McClellan², J. Buggs¹, E. Rogers¹, K. Barber¹, K. Cocuy¹, A. Kumar²
¹Tampa General Hospital, Tampa, FL, ²University of South Florida, Tampa, FL
*Purpose: The purpose of this study was to determine any difference in resource utilization since the implementation of the mandatory six month wait-time policy for…
2019 American Transplant Congress
Immunologic Outcomes In Recipients Of Orthotopic Liver Transplant Induced Only With Steroids
S. N. Merwat, A. T. Chatila, M. Bilal, R. Kulkarni, H. L. Stevenson, J. H. Fair, S. K. Merwat, T. Kozlowski, M. A. Mujtaba
The University of Texas Medical Branch, Galveston, TX
*Purpose: Liver allografts are resistant to antibody mediated rejection (AMR) in the presence of preformed alloantibodies. In most cases donor specific antibodies (DSAs) disappear a…
2019 American Transplant Congress
High-Throughput Immune Synapse Detection as a Tool for the Measurement of T Cell Alloreactivity
S. Moshkelgosha, S. C. Juvet
UHN, Toronto, ON, Canada
*Purpose: Measurement of T cell alloreactivity may facilitate a more accurate prediction of graft outcome and the selection of patients for immunosuppression optimization. However, current…
2019 American Transplant Congress
BK Virus Infection Disparity between Black and Other Races; Do Not Blame the Mycophenolic Acid
N. Raj¹, R. Spong¹, S. Jackson², V. Vakil¹, D. Keys¹, E. Finger³, S. Riad¹
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, Fairview Health Services, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Disparities in kidney transplant outcomes between black recipients and others continue to exist. We sought to examine the impact of race and the differential…